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Abstract 
Accurate identification of bacterial pathogens from clinical specimens and Multidrug 
Resistant (MDR) characterization is a key to empirical therapy. Twelve (12) bacteria isolates 
from blood, urine and faecal samples were selected based on the ability to grow on Luria 
Bertani (LB) agar medium containing 100µg/ml ampicillin, identified by 16S rDNA PCR and 
sequencing. Identified isolates tagged; U01, U02, U03, U04, S08, U10 and U11 were from 
urine specimens, S05, S06, S07 and S12 from stool, while B09 was from blood. The isolates 
were screened for MDR pattern according to Kirby-Bauer disc diffusion method. Conventional 
biochemical tests revealed that all the isolates are Escherichia coli. The 16S gene sequencing 
results confirmed that, ten (10) isolates had high similar sequence alignment with identified 
E. coli strains, while two are Enterobacter cloacae and P. aeruginosa. The antimicrobial 
susceptibility pattern shows that, most of the isolates (83.3%) were MDR. All the 12 isolates 
(100%) are resistant to Ampicillin, Cephalothin, Erythromycin, Fusidic acid, Novobiocin and 
Oxacillin, but sensitive to Colistin sulphate and Imipenem. Eleven isolates (91.7%) are 
resistant to Chloramphenicol, Cotrimoxazole, Streptomycin, Sulphatriad and Tetracycline. 
Eight of the 12 isolates (66.7%) are resistant to Ciprofloxacin and Ceftriaxone. Seven 
(58.3%) are resistant to Cefotaxime, Cefuroxime and Gentamycin. Nine (75%) are sensitive 
and three isolates (25%) are resistant to Augmentin. The high resistance to these 
antibacterial agents in this study was due to the indiscriminate use of first-line common 
antibiotics like ampicillin in the study area, which is now substituted with Augmentin. 
Routine biochemical identification tests should always be confirmed with genotypic methods 
such as 16S gene sequencing, to avoid misdiagnosis, as variations do exist among some 
bacterial strains. 
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Introduction 
Proper identification of bacterial isolates 
is a major role of clinical diagnostic microbiology.  
However, conventional routine laboratory 
techniques are cheaper and faster in 
identification of most of the commonly 
encountered bacterial pathogens, some species 
are not easily identified. These methods also 
have shortcomings due to emergence of 
uncommon bacteria or those species with 
ambiguous metabolic properties (Munkhdelger et 
al., 2017). For variable, slow-growing bacteria to 
be identified, adequate time and standard 
laboratory working conditions are needed. These 
requirements are hardly met in our laboratories, 
due to ill-equipment and poor electricity supply. 
16S ribosomal DNA sequencing serve as a 
universal techniques that basically, provides 
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solutions to problems encountered in 
conventional methods, yielding authentic results, 
even for all types of bacteria species. 16S rDNA 
sequencing is useful in identification of those 
bacteria that cannot be easily detected 
phenotypically. Molecular identification of 
bacterial isolates from clinical specimens is more 
sensitive and reliable, as some significant 
pathogens are missed during conventional 
routine laboratory screening.  
Resistance of bacteria to common 
antimicrobial agents is a great threat to public 
health globally. Dissemination of multidrug-
resistance among bacterial pathogens is 
commonly found to be plasmid-mediated. MDR 
bacterial strains have increased with the 
application of broad-spectrum antibacterial 
agents. A large number of drug-resistant genes 
have been reported (Li et al., 2012; Zhou et al., 
2018). Multidrug resistance have negative 
impact on the treatment of infections caused by 
bacterial pathogens from both intestinal and 
extraintestinal sites. The multiple levels of 
resistance transmission make elucidation of the 
antimicrobial chemotherapy of 
Enterobacteriaceae extremely complicated (Abd 
El Ghany et al., 2018). This study was therefore 
aim at identifying bacterial isolates from clinical 
specimens using 16S rDNA analysis and 
determining the multidrug resistant pattern of 
the isolates. 
 
Materials and Methods 
 
Phenotypic identification and selection of 
bacterial isolates 
A total of twelve (12) isolates were 
identified based on the conventional phenotypic 
characteristics; Gram reaction, indole, citrate, 
urease, triple sugars and using analytical profile 
index (API 20E) test strips (Biomurieux, France). 
The isolates were selected for molecular studies 
by their ability to grow on Luria-Bertani (LB) 
agar medium containing 100µg/ml ampicillin 
(Melford Laboratories, UK), as described by 
Sambrook and Russel (2001).  
Molecular identification of bacterial 
isolates 
Colony PCR amplification of 16S rDNA gene 
The isolates were screened by 16S colony 
PCR for bacterial species identification. A total 25 
µl was used as the PCR volume, which 
comprised of 12.5µl master mix/My Taq 
polymerase, 10.5µl double distilled water, 1µl 
each of forward and reverse primers. From 
overnight culture plate, a sterile pipette tip was 
used to picked and transfer a single bacterial 
colony into the reaction tube (0.2ml Eppendorf 
tube). The PCR was performed in G-Storm 
thermocycler, GS 00001 (ThermoFisher 
Scientific, UK). The following PCR reaction 
conditions was used: Initial denaturation at 94°C 
for 3minutes, then 35 cycles of denaturation 
(95°C for 45 seconds), annealing (56°C for 30 
sec) and extension (72°C for 1 minute), with a 
final extension at 72°C for 3 mins. A molecular 
marker 1 kb DNA Hyperladder (Bioline, UK) was 
used to assess PCR product size. The products 
were separated by gel electrophoresis on 1% 
agarose, stained with gel red and the image 
were captured digitally with UV transillumination 
using G:Box Chemi-XX6 (Syngene, UK). The 
characteristics of the universal primer used for 
the species identification is given below. 
 
Characteristics of primer for amplification of 16S rDNA in the target bacterial species  
 
Gene        Primer    Oligonucleotide sequence (5΄- 3΄)   Size (bp)   
 Reference 
 
16SrDNA    UNI F  GAGTTTGATCCTGGCTCAG        1500       Barghouthi, 
             UNI R     GGACTACCAGGGTATCTAAT        (2011) 
 
16S rDNA purification, quantification and 
Sequencing 
The 16S rDNA colony PCR products 
were clean-up using QIAquick PCR purification 
kit/protocol (Qiagen, UK). The clean products 
was quantified using Cubit 4 Fluorometer 
(ThermoFisher Scientific, UK). DNA purity was 
estimated by Lambda XLS UV 
Spectrophotometer, L7110191 (Perkin-Elmer 
Inc., USA). UV absorbance at 260, 280, and 230 
was measured according to manufacturers’ 
instructions. The absorbance at 260 nm (A260) 
and at 280 nm (A280) for the DNA was measured 
to determine its purity. The quantified DNA was 
finally analyzed by sequencing techniques for 
the species identification at the Medical 
Research Institute, University of Dundee, UK.  
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Screening of isolates for multidrug resistance 
(MDR)  
The isolates were screened for 
antimicrobial susceptibility pattern, multidrug 
resistant characteristics on Iso-sensitest agar 
(ISA) media (Oxoid, UK), using McFarland 
standard inoculum  according to Kirby-Bauer disc 
diffusion methods as described by (Mahon et al., 
2007). The following commercial discs were 
used:  Combined discs M13/M14 rings (Mast 
Diagnostics, UK): Chloramphenicol (5µg), 
Erythromycin (5µg), Fusidic acid (10µg), 
Oxacillin (5µg), Novobiocin (5ugµg), Penicillin 
(1I.U), Streptomycin (10µg), Tetracycline 
(25µg), and M14 rings: Ampicillin (10 µg), 
Cephalothin (5µg), Colistin sulphate (25µg), 
Gentamycin (10µg), Sulphatriad (200µg), and 
Cotrimoxazole (25 µg). Single discs (Oxoid): 
Amoxycillin-clavulanate/Augmentin (30µg), then 
Imipenem (10µg), Cefuroxime (30µg), 
Ceftriaxone (30µg), Cefotaxime (30µg), 
Ciprofloxacin (10µg) and. The diameter zone of 
inhibition were measured in millimetre and 
results were interpreted according to British 
society for antimicrobial chemotherapy (BSAC) 
guidelines, (2013). Escherichia coli NCTC 11560 
and E. coli ATCC 35401 was used as positive 
control; while E. coli K-12 DH5α as negative 
control. 
 
Results and Discussion 
Antimicrobial drug resistance is a great 
threat for therapeutic failure in human medicine. 
The presence of Enterobacteria, especially 
multidrug resistant Escherichia coli, has 
increased during past decades in terms of the 
worldwide distribution of resistance traits and 
evolution of different genes. In this study, the 
conventional biochemical profile revealed that 
all the isolates are Escherichia coli. Isolates U01, 
U02, U03, U04, U10 and U11 were from urine 
specimens, S05, S06, S07, S08 and S12 from 
stool, while B09 was from blood. But when the 
API 20E test was used to identify the isolates, 
the results interpretation in the test manual 
show that three isolates were E. coli, 
Enterobacter cloacae and Kluvera sp., and no 
identification for the remaining nine isolates. 
These results indicated that conventional 
biochemical identification tests should always be 
confirmed with genotypic methods such as 16S 
gene sequencing.  
Use of 16S rDNA PCR and sequencing for 
bacterial species identification  
The use of 16S rDNA sequencing in 
clinical microbiology laboratories for bacterial 
identification, the discovery of novel bacterial 
genera and species, the detection of 
uncultivable bacteria and the diagnosis of 
culture-negative infections are reviewed by 
some studies (Esparcia et al., 2008; Sontakke et 
al., 2009; Barghouthi, 2011). In this study 
(Figure 5), 16S rDNA species identification by 
PCR and sequencing confirmed that all the 
isolates were E. coli with the exception of 
isolates U01 and S08 which were identified as 
Enterobacter cloacae and Pseudomonas 
aeruginosa respectively. A PCR product of 1500 
bp was detected for all the isolates under gel 
documentation system. The variation in the 
biochemical properties of isolates in this study 
revealed the importance of molecular 
identification methods for clinical bacterial 
isolates in order to avoid misdiagnosis. This is 
due to the fact that our isolates were carefully 
identified using conventional biochemical tests 
as E. coli which differ in the case of API 20E 
test, but confirmed with 16S rDNA sequencing.  
 
Concentration and purity level of DNA extract 
After a successful DNA extraction from bacterial 
isolates, it is a common practice to quantify the 
DNA prior to using it in downstream 
applications. To ensure optimal performance, 
reactions that utilize 16S rDNA or rRNA gene 
sequencing for bacterial species identification 
typically specify the required quantities of 
nucleic acid. In this study (Table 1), purity and 
concentration of amplified 16S rDNA PCR 
products from the bacterial isolates was 
quantified using spectroscopy and cubit 



























Figure 1: Agarose gel image of 16S rDNA PCR products with amplicon size of 1500 bp specific to 
Enterobacteriaceae, like Escherichia coli. Lane M is a DNA Hyperladder/molecular marker (Bioline, 
UK). 
 
The absorbance ratio, A260/A280 was found 
to be between 1.4 and 2.8. This shows that the 
rDNA extracts from eleven isolates (92%) is 
pure, as it fall within the normal range of high 
quality DNA (1.8-2.0) (Glasel, 1995). Isolate 
B09 had low purity level, but with high DNA 
concentration which is significant for 
identification. In a study by Ibrahim et al. 
(2014) the ratio of A260/A280 was found to be 
between 1.65 and 1.84, after bacterial DNA 
purity estimation using NanoDrop technique. 
 
Bacterial strains with 16S gene sequence 
producing significant alignment 
Medical diagnostic microbiology 
laboratories consider proper identification of 
pathogenic bacteria as their major tasks. This 
allow the scientist to differentiate between 
virulent and avirulent strains, as well as 
contaminants from mixed cultures, which paves 
way effective chemotherapeutic intervention, 
based on patient’s underlying clinical condition. 
In this study (Table 2), the 16S gene 
sequencing for bacterial species identification 
revealed that, 10 isolates had high similar gene 
sequence alignment with the identified E. coli 
strains, while two are Enterobacter cloacae and 
P. aeruginosa strains. Eight isolates had 16S 
rRNA gene partial sequence and four are 
chromosomal DNA complete genome. Isolate 
U01 was an Enterobacter cloacae strain HFZ-H4 
16S ribosomal RNA gene, partial sequence 
(MG255304.1). Enterobacter cloacae is one of 
the commensal enterobacteria that is highly 
adaptive to different ecological niche. It is 
responsible for cases of disease outbreak in a 
hospital settings as an opportunistic pathogen 
(Keller et. al., 1998). 
E. cloacae has an intrinsic resistance to 
ampicillin and narrow-spectrum cephalosporins 
and exhibits a high frequency of mutation to 
resistance to expanded-spectrum and broad-
spectrum cephalosporins. Isolate U03 is 
Escherichia fergusonii strain BI14 16S ribosomal 
RNA gene, partial sequence (KC986858.1) E. 
fergusonii is a new species in the genus 
Escherichia and family Enterobacteriaceae with 
a 64% homology to Escherichia coli after 
analysis by DNA hybridization techniques. The 
strain was isolated from cheese, some patients’ 
gall bladder, poultry and livestock faeces. 
(Glover et. al., 2017). 
In this study, 16S gene from isolate U08 
has somewhat similar sequence alignment, 89% 
homology with P. aeruginosa R7-539 16S rRNA 
partial sequence (JQ659890.1). Pseudomonas 
aeruginosa is a MDR bacteria recognized for its 
ubiquity, its intrinsically high antimicrobial 
resistance mechanisms, and its association with 
serious illnesses, nosocomial infections like 
pneumonia and sepsis. The organism was 
identified as an opportunistic pathogens, 
occurring during such disease conditions as 
cystic fibrosis, traumatic burns and folliculitis. 
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These infections can be difficult treat due to 
inherent resistance to antibiotics and adverse 
contraindications especially with administration 
of new antimicrobial agents (Klockgether et. al., 
2011).  
Table 1: Concentration and purity level of the amplified 16S rDNA 
       
   Samples  UV Absorbance/O.D (nm)  Absorbance ratio  DNA Conc. (ng/μl) 
   260  280  (purity level)              
 
U01  0.032  0.020  1.6   1665 
U02  0.017  0.006  2.8   1224 
U03  0.023  0.012  1.9   1134 
U04  0.088  0.017  2.1   1190 
U06  0.024  0.013  1.8   1088 
U10  0.054  0.023  1.7   1176 
U11  0.032  0.010  2.3   2080 
S05  0.090  0.015  2.2   1380 
S07  0.043  0.012  2.0   1220 
S08  0.025  0.009  2.8   3610 
S12  0.058  0.018  2.0   5750 
B09  0.088  0.065  1.4   1020 
This study found that the isolate B09 
from specimen was E. coli WG5 
chromosomal DNA, complete genome 
sequence (CP024090.1). Escherichia coli 
strain WG5 is a commonly used bacterial 
strain used in the identification of phages 
and as indicator of water pollution by faecal 
matter. The mutant E. coli WG5 is resistant 
to Nalidixic acid with increased susceptibility 
to phage infections (Imamovic et. al., 2018). 
Isolate U11 was similar to E. coli O157:H7 
EDL933 with chromosomal DNA, complete 
genome sequence (AE005174.2). It is a 
serotype of Shigatoxin-producing E. coli 
(STEC), responsible for foodborne diseases, 
associated with contaminated dairy products, 
raw or semi-cooked food. The disease leads 
to such complications as haemorrhagic 
colitis, uremic syndrome, and death in young 
children. (Gally & Stevens, 2017). 
 
Table 2: 16S DNA sequence producing significant alignment for species Identification  
  
Isolate Identified strain Gene  Type of genome Sequence ID % ID  
              
U01 Ent. cloacae HFZ-H4  16S rRNA   partial sequence  MG255304.1
 97  
U02     E. coli isolate 32c   16S rRNA   partial sequence  LK985352.1
 97                   
U03      E. fergusonii BI14  16S rRNA partial sequence  KC986858.1 85
   U04 E. coli STEC299  cDNA   complete genome  CP022279.1  99
  
S05 E. coli RCB250  16S rRNA  partial sequence  KT260462.1 97  
S06 E. coli AR-0081  cDNA   complete genome  CP027534.1  98  
S07 E. coli PD3   16S rRNA partial sequence  FR715025.1
 98  
S08 P. aeruginosa R7-539  16S rRNA   partial sequence  JQ659890.1 89
  
B09 E. coli WG5   cDNA   complete genome  CP024090.1 96  
U10 E. coli BJ11203  16SRNA  partial sequence  KP235234.1 97  
U11 E. coli O157:H7  EDL933  complete genome  AE005174.2  98  
S12 E. coli RCB250  16S rRNA  partial sequence  KT260462.1 99   
 
These are the highest % ID given in the NCBI data base after blasting. The sequence ID numbers can be 
used to confirm. 
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Multidrug resistant characteristics of the 
isolates 
Multidrug resistance in bacteria is most 
commonly associated with the presence of 
plasmids which contain one or more resistance 
genes, each encoding a single antibiotic 
resistance phenotype. In the present study, 
table (3) All the twelve isolates (100%) are 
resistant to Ampicillin, Cephalothin, 
Erythromycin, Fusidic acid, Novobiocin and 
Oxacillin. Eleven isolates (91.7%) are resistant 
to Chloramphenicol, Cotrimoxazole, 
Streptomycin, Sulphatriad and Tetracycline. 
Eight isolates (66.7%) are resistant to 
Ciprofloxacin and Ceftriaxone. Seven isolates 
(58.3%) are resistant to Cefotaxime, 
Cefuroxime and Gentamycin. Nine (9) isolates 
(75%) are sensitive and three (3) isolates 
(25%) are resistant to Augmentin. However, the 
isolates were sensitive to Colistin sulphate 
(100%), Imipenem (100%), and Augmentin 
(75.0%).  The E.coli isolates U03, U04, S05, 
S06, S07, B09, U10, U11 and S12 were sensitive 
to Augmentin and at least five of the isolates 
are also sensitive to Cefotaxime, Ceftriaxone, 
Cefuroxime and Gentamycin. The result showed 
higher resistance of the isolates to beta-lactams 
like ampicillin which alarms us that such drugs 
should no longer be used as first line of 
treatments in this area, as it used to be in the 
previous decades. These results of ampicillin-
resistant E.coli are congruent to the report of 
Farshad et. al. (2012), who found 100% 
resistance of their E.coli isolates to ampicillin. 
A maximum resistance among E. coli 
species isolates was observed against 
cefpodoxime 100% by Sahu et. al. (2011).The 
presence of multidrug resistance in this study 
may be related to the dissemination of antibiotic 
resistance among hospital isolates. Lim et. al. 
(2009) observed that Escherichia coli are one of 
the main bacterial pathogens responsible for 
nosocomial infections especially in 
immunocompromised patients. The sensitivity of 
E. coli isolates to imipenem was also very high 
as reported in a previous study by Farshad et. 
al. (2012). This signifies that this drug can be 
used as the best option against Uropathogenic 
E. coli (UPEC).  
Urinary tract infection (UTI) is one of 
the commonest infectious disease of human 
population, caused by multidrug resistant E. coli 
(MDREC) (Hadifar et. al., 2017). In this study 
(Table 3), isolates from various cases of UTI 
had the highest prevalence of MDR to 
commonly used antibiotics, including the third 
and fourth generation cephalosporins. In a 
study by Munkhdelger et. al. (2017) in 
Mangolia, the most common antibiotic 
resistance was to Cephalothin (85.1%), 
ampicillin (78.4%) and the least to 
nitrofurantoin (5.4%) and imipenem (2%), 
where 93.9% of the isolates were multidrug 
resistant. The antibiotic resistance profiling of 
UPEC strains in some reports (Lee et al., 2016) 
elucidates that the antimicrobial agents such as 
chloramphenicol, cefoxitin, Cefepime, 
ceftazidime might still be used in the treatment 
UTIs. Jan et. al. (2009) reported a high 
potentiality of E.coli in developing antimicrobial 
resistance. This study observed an emergence 
MDR to third-generation cephalosporins. In 
Nigeria, the emergence of multidrug resistant 
strains and its variation over the years has been 
increasing (Aibinu et. al., 2003).  
Enterobacter cloacae is clinically 
important Gram-negative member of the 
Enterobacteriaceae and emerging pathogen, 
causing various nosocomial infections. In this 
study, the Enterobacter isolate (U01), is 
resistant all antibiotics tested except Colistin 
sulphate and Imipenem. The similar MDR 
pattern other isolates from this study should 
necessitate an investigation to determine 
whether a limited spread of a particular isolate 
existed and also to investigate the mode of 
resistance to new generation of beta-lactam 
antibiotics.  Enterobacter cloacae resistant to 
extended-spectrum cephalosporins was reported 
as aetiologic agents of disease among neonates 
in a Greek hospital (Kartali et. al., 2002). 
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Table 3: Distribution of bacterial isolates according to multidrug resistant pattern   
            
Antibiotics (µg)     Bacterial isolates and Zone of Inhibition (mm)/Susceptibility pattern   
 
Std. (mm) U01 U02 U03 U04 S05 S06 S07 S08 B09 U10 U11 S12 %MDR 
 
Ampicillin (10)  15  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0)      (100)     
Augmentin (30)  13  (0.0) (0.0) (15.3) (14.2) (0.0) (0.0) (15.7) (16.1) (17.8) (16.2) (13.0) (23.5) (33.3) 
Cefotaxime (30) 20  (0.0) (0.0) (39.3) (12.8) (32.3) (0.0) (10.5) (12.0) (37.8) (36.4)  (0.0) (35.2) (58.3) 
Ceftriaxone (30) 24  (0.0) (0.0) (34.1) (12.3) (34.2) (0.0) (10.0) (11.6) (29.2) (35.2) (13.4) (33.5) (66.7)  
Cefuroxime (30) 24  (0.0) (0.0) (24.2) (0.0) (24.4) (0.0) (0.0) (0.0) (26.8) (25.5) (0.0) (28.0) (58.3)  
Cephalothin (5)  15  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Chloramphenicol (25) 21  (0.0) (16.4) (21.3) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (11.8) (0.0) (0.0) (91.7) 
Ciprofloxacin (5) 17  (0.0) (0.0) (0.0) (0.0) (30.8) (0.0) (0.0) (0.0) (32.2) (36.5) (0.0) (26.1) (66.7) 
Cotrimoxazole (25) 16  (8.1) (0.0) (14.2) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Colistin sulphate (25) 14  (16.5) (17.8) (20.3) (16.7) (16.2) (17.3) (18.8) (17.2) (19.1) (17.0) (17.2) (19.1) (0.00) 
Erythromycin  (5) 17  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Fusidic acid (10)  30  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Gentamycin (10) 17  (8.7) (25.6) (0.0) (0.0) (20.2) (0.0) (0.0) (0.0) (24.4) (23.6) (23.1) (7.4) (58.3) 
Imipenem (10)  17  (29.3) (33.4) (36.1) (32.3) (30.2) (27.4) (33.2) (31.5) (33.1) (35.3) (32.1) (30.2) (0.00) 
Novobiocin (5)  16  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Oxacillin (5)  15  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Penicillin G (1I.U) 15  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100) 
Streptomycin (10)  15  (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (18.2) (10.8) (91.7)   
Sulphatriad (200) 14  (0.0) (0.0) (29.8) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (91.7) 
Tetracycline (25) 30  (0.0) (0.0) (14.9) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (100)  
  
Standard zone of inhibition interpreted according to BSAC guidelines, 2013




Pseudomonas aeruginosa is one of the major 
nosocomial and multidrug resistant (MDR) 
bacterial pathogen. The diseases are difficult to 
treat because of the limited susceptibility to 
antibiotics and the high frequency of an 
emergence of antimicrobial resistance during 
treatment leading to adverse contraindications 
(Aloush et. al., 2006). In this study, isolates S08 
is also sensitive to Augmentin, Colistin sulphate 
and Imipenem, as in the case of E. coli and 
Enterobacter cloacae strains from this study; 
but are resistant to the other 17 antibiotics 
tested. These findings revealed the importance 
of beta-lactam inhibitors and carbapenems as a 
therapeutic options against these bacteria.  
 
Conclusion 
This study observed that poor chemotherapeutic 
approach and self-medication have contributed 
to the emergence of multidrug resistance in the 
area. High resistance against the commonly used 
antibacterials is alarming. Conventional 
biochemical identification tests should always be 
confirmed with molecular techniques such as 
16S gene sequencing, to ensure accurate 
diagnosis of bacterial infections. 
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